Etoposide Injection
Product Images NDC 0143-9512

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 0143-9512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Etoposide Injection Usp 1)

Structural Formula (Etoposide Injection Usp 1)
Chemical structure of Etoposide, showing its molecular arrangement with multiple rings, oxygen atoms, and hydroxyl groups, consistent with its identity as the active ingredient in Etoposide injection.*
FDA Label Image

Vial Label For Etoposide Injection, Usp 100 mg/5 mL (Etoposide Injection Usp 2)

Vial Label For Etoposide Injection, Usp 100 mg/5 mL (Etoposide Injection Usp 2)
Etoposide Injection, USP 100 mg/5 mL (20 mg/mL) in a 5 mL multiple dose vial. The label indicates the product contains 20 mg etoposide per mL and is for intravenous administration. The vial is manufactured by Hikma Pharmaceuticals USA Inc., located in Eatontown, NJ. Storage instructions and dosage volume details are also visible.*
FDA Label Image

Vial Label For Etoposide Injection, Usp 500 mg/25 mL (Etoposide Injection Usp 3)

Vial Label For Etoposide Injection, Usp 500 mg/25 mL (Etoposide Injection Usp 3)
Etoposide Injection USP 500 mg/25 mL (20 mg/mL) multiple dose vial label. Contains Etoposide 20 mg per mL in a 25 mL vial. The label includes dosage instructions to refer to the package insert, dilution requirement before intravenous infusion, and storage conditions between 20° to 25°C. Manufactured by THYMOORGAN PHARMAZIE GmbH and distributed by Hikma Pharmaceuticals USA Inc., West-Ward, Eatontown, NJ.*
FDA Label Image

Vial Label For Etoposide Injection, Usp 1 G/50 mL (Etoposide Injection Usp 4)

Vial Label For Etoposide Injection, Usp 1 G/50 mL (Etoposide Injection Usp 4)
Etoposide 1 g/50 mL (20 mg/mL) intravenous infusion injection label from Hikma Pharmaceuticals USA Inc. The label indicates it is a 50 mL multiple dose vial with dosage units noted in mg/mL. Directions state it must be diluted before infusion, with specific storage instructions and manufacturing information included.*
FDA Label Image

Representative Carton Serialization Image (Etoposide Injection Usp 5)

Representative Carton Serialization Image (Etoposide Injection Usp 5)
A medication label for Etoposide injection 20 mg/mL by Hikma Pharmaceuticals USA Inc. The label includes a QR code and text fields showing GTIN, serial number, expiration date, and lot number placeholders in a standardized format for tracking and identification.*
FDA Label Image

Representative Carton Serialization Image (Etoposide Injection Usp 6)

Representative Carton Serialization Image (Etoposide Injection Usp 6)
Label for Etoposide injection 20 mg/mL by Hikma Pharmaceuticals USA Inc. The label includes a lot number, expiration date, a GTIN barcode, and a serial number, presented in a clear format adjacent to a Data Matrix barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.